- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
10 CBD Company Health Claims: Please Read
FDA on July 23rd issued a warning letter to CBD-producer Curaleaf, Inc, citing unsubstantiated health claims for its products. Here are 10 of the claims your patients are reading.
On Tuesday, July 23, 2019, the FDA issued a warning letter to Curaleaf, Inc, of Wakefield, Mass, for unsubstantiated health claims made about its wide range of cannabidiol (CBD)-based products. Among the company's many therapeutic claims are that its CBD oil treats cancer, opioid withdrawal, Alzheimer disease, heart disease, and pet pain and anxiety. The products marketed include tinctures, lotions, pain patches, and disposable vape pens. Click through the slides below for 10 examples of the specific claims for CBD oil made by Curaleaf. This is what your patiets are reading.Â
